TIG Advisors LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-184,622
Closed -$11.7M 407
2021
Q1
$11.7M Sell
184,622
-332,805
-64% -$20.7M 0.44% 45
2020
Q4
$32.1M Buy
+517,427
New +$31.8M 1.61% 10
2019
Q2
Sell
-383,438
Closed -$17.9M 53
2019
Q1
$18.3M Buy
+383,438
New +$19.1M 0.76% 24

Other funds holding BMY

TIG Advisors LLC's BMY Position: Q2 2021 in Review

TIG Advisors LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 184,622 shares — an estimated $11.7M sold.

TIG Advisors LLC first reported a position in BMY in Q1 2019 and held it in 3 quarters. The position peaked at $32.1M in Q4 2020. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • TIG Advisors LLC reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • TIG Advisors LLC sold 184,622 Bristol-Myers Squibb shares in Q2 2021, an estimated $11.7M.
  • TIG Advisors LLC first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 3 quarters.
  • TIG Advisors LLC's Bristol-Myers Squibb position peaked at $32.1M in Q4 2020.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on TIG Advisors LLC's 13F filing for Q2 2021, filed 16 Aug 2021.